1,836
Views
27
CrossRef citations to date
0
Altmetric
Commentary

Degradative autophagy selectively regulates CCND1 (cyclin D1) and MIR224, two oncogenic factors involved in hepatocellular carcinoma tumorigenesis

, &
Pages 729-730 | Received 18 Sep 2018, Accepted 03 Dec 2018, Published online: 31 Jan 2019

Figures & data

Figure 1. A schematic hypothetical diagram of degradative autophagy, selective regulation of MIR224 and CCND1 and evidence of MIR224 and CCND1 coexistence in the autophagosome. (a) CCND1 is selectively recruited to the phagophore through the specific receptor SQSTM1. MIR224 is preferentially recruited to the phagophore by unknown factors. Both of the oncogenic factors are present in autophagosomes after selective recruitment; subsequent autophagosome fusion with the lysosome is followed by degradation. (b) Human liver cancer Hep 3B cells were treated with the autophagy inducer amiodarone. Coexistence of immunogold-labeled CCND1 (12-nm bead) and MIR224 (20-nm bead) after miRNA in situ hybridization in the purified autophagosomes was investigated using TEM. Scale bar: 100 nm.

Figure 1. A schematic hypothetical diagram of degradative autophagy, selective regulation of MIR224 and CCND1 and evidence of MIR224 and CCND1 coexistence in the autophagosome. (a) CCND1 is selectively recruited to the phagophore through the specific receptor SQSTM1. MIR224 is preferentially recruited to the phagophore by unknown factors. Both of the oncogenic factors are present in autophagosomes after selective recruitment; subsequent autophagosome fusion with the lysosome is followed by degradation. (b) Human liver cancer Hep 3B cells were treated with the autophagy inducer amiodarone. Coexistence of immunogold-labeled CCND1 (12-nm bead) and MIR224 (20-nm bead) after miRNA in situ hybridization in the purified autophagosomes was investigated using TEM. Scale bar: 100 nm.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.